Thomas Gad - 07 Mar 2025 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Signature
/s/ John LaRocca, Attorney-in-Fact
Issuer symbol
YMAB
Transactions as of
07 Mar 2025
Transactions value $
-$56,536
Form type
4
Filing time
11 Mar 2025, 20:15:41 UTC
Previous filing
22 Jan 2025
Next filing
05 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$56.5K -10.8K -5.06% $5.23 203K 07 Mar 2025 Direct F1, F2
holding YMAB Common Stock 67.7K 07 Mar 2025 By GAD Enterprises LLC F3
holding YMAB Common Stock 60K 07 Mar 2025 By Children F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $5.15 to $5.27, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Reporting Person is sole member of GAD Enterprises, LLC and the sole member and manager of GAD Management, LLC, the manager of GAD Enterprises, LLC, and as such Reporting Person has sole voting and dispositive power with respect to such shares.
F4 Represents shares owned by Reporting Person's children who are deemed to share Reporting Person's household.